相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2
Liliana Guedez et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Evaluation of genetic variation contributing to differences in gene expression between populations
Wei Zhang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group
Beverly J. Lange et al.
BLOOD (2008)
Pharmacogenetics of deoxycytidine kinase: Identification and characterization of novel genetic variants
Jatinder K. Lamba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
RAD51AP1 is a structure-specific DNA binding protein that stimulates joint molecule formation during RAD51-mediated homologous recombination
Mauro Modesti et al.
MOLECULAR CELL (2007)
Promotion of homologous recombination and genomic stability by RAD51AP1 via RAD51 recombinase enhancement
Claudia Wiese et al.
MOLECULAR CELL (2007)
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach
R. Stephanie Huang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity
R. Stephanie Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Effect of population and gender on chemotherapeutic agent-induced cytotoxicity
Rong Stephanie Huang et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Effect of race on outcome of white and black children with acute myeloid leukemia: The St. Jude experience
Jeffrey E. Rubnitz et al.
PEDIATRIC BLOOD & CANCER (2007)
Drug resistance in childhood acute myeloid leukemia
J. Styczynski
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
ERK1/2 MAP kinases in cell survival and apoptosis
Zhimin Lu et al.
IUBMB LIFE (2006)
Pir51 a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks
Sarah E. Henson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group
R Aplenc et al.
BLOOD (2006)
Curing childhood acute myeloid leukemia (AML) at the half-way point: Promises to keep and miles to go before we sleep
WG Woods
PEDIATRIC BLOOD & CANCER (2006)
Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter
SM Fitzgerald et al.
HUMAN GENETICS (2006)
Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics
JA Gilbert et al.
CLINICAL CANCER RESEARCH (2006)
Mitoferrin is essential for erythroid iron assimilation
GC Shaw et al.
NATURE (2006)
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia
I Hubeek et al.
BRITISH JOURNAL OF CANCER (2005)
GIT1 is a scaffold for ERK1/2 activation in focal adhesions
GY Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222
JO Moore et al.
BLOOD (2005)
Pharmacogenomics in admixed populations
G Suarez-Kurtz
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC)
P Fernandez-Calotti et al.
LEUKEMIA & LYMPHOMA (2005)
Comparison of alamar blue and MTT assays for high through-put screening
R Hamid et al.
TOXICOLOGY IN VITRO (2004)
Gene expression profiling of pediatric acute myelogenous leukemia
ME Ross et al.
BLOOD (2004)
GIT1 functions as a scaffold for MEK1-extracellular signal-regulated kinase 1 and 2 activation by angiotensin II and epidermal growth factor
GY Yin et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia
MA Sekeres et al.
BLOOD (2004)
Problems related to resistance to cytarabine in acute myeloid leukemia
E Cros et al.
LEUKEMIA & LYMPHOMA (2004)
Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine
CM Galmarini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461)
JC Byrd et al.
BLOOD (2002)
Progress and controversies in the treatment of pediatric acute myelogenous leukemia
RJ Arceci
CURRENT OPINION IN HEMATOLOGY (2002)
Potential mechanisms of resistance to cytarabine in AML patients
CM Galmarini et al.
LEUKEMIA RESEARCH (2002)
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia
CM Galmarini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia
CM Galmarini et al.
BLOOD (2001)
Noncardiogenic pulmonary edema: An unusual and serious complication of anticancer therapy
E Briasoulis et al.
ONCOLOGIST (2001)
A general test of association for quantitative traits in nuclear families
GR Abecasis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
